LIMNW vs PLTR
Liminatus Pharma, Inc. Warrants (LIMNW) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
LIMNW does not have a complete income-statement cache yet.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
LIMNW currently screens at market cap $0. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the LIMNW and PLTR stock pages for the full models.
Not investment advice.